Altitud y letalidad por COVID-19 durante la pandemia en el Perú, 2020-2022

Rodrigo Robles-Mariños; Diego Fano-Sizgorich; Germán F. Alvarado; Gustavo F. Gonzales

doi:10.17843/rpmesp.2026.431.14979

Authors

Rodrigo Robles-Mariños Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú. Laboratorio de Endocrinología y Reproducción, Facultad de Ciencias e Ingeniería, Departamento de Ciencias Biológicas y Fisiológicas, Universidad Peruana Cayetano Heredia, Lima, Perú https://orcid.org/0000-0002-0046-4003
Diego Fano-Sizgorich Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú. Laboratorio de Endocrinología y Reproducción, Facultad de Ciencias e Ingeniería, Departamento de Ciencias Biológicas y Fisiológicas, Universidad Peruana Cayetano Heredia, Lima, Perú https://orcid.org/0000-0001-7172-0521
Germán F. Alvarado Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú https://orcid.org/0000-0003-4531-7717
Gustavo F. Gonzales Facultad de Ciencias de la Salud, Universidad San Ignacio de Loyola, Lima, Perú. https://orcid.org/0000-0003-1611-2894

DOI:

https://doi.org/10.17843/rpmesp.2026.431.14979

Keywords:

COVID-19, Case Fatality, Mortality, Altitude, Peru

Abstract

Objectives. To evaluate the functional form of the association between the district altitude of residence and the case fatality rate of COVID-19 cases in Peru during the 2020-2022 period. Materials and methods. A
retrospective cohort study was conducted using secondary data from the Ministry of Health of Peru on COVID-19 cases and deaths. District altitude of residence was categorized into four groups (0-500; 501-
2,000; 2,001-3,500; and ≥3,501 masl). The outcome was death from COVID-19 according to the official death registry. Poisson regression was used to estimate adjusted relative risks for individual and contextual variables, using robust variance clustered by district. The analyses were repeated according to the five epidemic waves that occurred between March 2020 and December 2022. Results. A non-linear association was observed between the altitude of residence and death from COVID-19, consistent with a “U-shaped” pattern, characterized by a lower risk of death in cases residing between 2,001 and 3,500 masl compared to those residing between 0 and 500 masl. This pattern remained consistent in the analyses stratified by epidemic wave. Conclusions. In Peru, during the 2020-2022 period, the data do not support a monotonic decrease in the risk of death from COVID-19 with increasing altitude of residence. On the contrary, the
results suggest a non-linear relationship, with lower lethality at intermediate altitudes (2,001–3,500 masl).

Downloads

Download data is not yet available.

References

Ramos W, Arrasco J, De La Cruz-Vargas JA, Ordóñez L, Vargas M, Seclén-Ubillús Y, et al. Epidemiological Characteristics of Deaths from COVID-19 in Peru during the Initial Pandemic Response. Healthcare. 2022;10(12):2404. doi: 10.3390/healthcare10122404.

Valdez Huarcaya W, Miranda Monzón JA, Napanga Saldaña EO, Driver CR. Impacto de la COVID-19 en la mortalidad en Perú mediante la triangulación de múltiples fuentes de datos. Rev Panam Salud Pública. 2022;46:e53. doi: 10.26633/RPSP.2022.53.

Kowsar R, Rahimi AM, Sroka M, Mansouri A, Sadeghi K, Bonakdar E, et al. Risk of mortality in COVID-19 patients: a meta- and network analysis. Sci Rep. 2023;13(1):2138. doi: 10.1038/s41598-023-29364-8.

Esmaeili ED, Azizi H, Sarbazi E, Khodamoradi F. The global case fatality rate due to COVID-19 in hospitalized elderly patients by sex, year, gross domestic product, and continent: A systematic review, meta-analysis, and meta-regression. New Microbes New Infect. 2023;51:101079. doi: 10.1016/j.nmni.2022.101079.

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. doi: 10.1038/s41586-020-2521-4.

Espinosa OA, Zanetti A dos S, Antunes EF, Longhi FG, de Matos TA, Battaglini PF. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med Trop São Paulo. 2020;62:e43. doi: 10.1590/S1678-9946202062043.

Legido-Quigley H, Asgari N, Teo YY, Leung GM, Oshitani H, Fukuda K, et al. Are high-performing health systems resilient against the COVID-19 epidemic?. Lancet Lond Engl. 2020;395(10227):848–50. doi: 10.1016/S0140-6736(20)30551-1.

Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet Lond Engl. 2020;395(10242):1973–87. doi: 10.1016/S0140-6736(20)31142-9.

Firouzabadi N, Ghasemiyeh P, Moradishooli F, Mohammadi-Samani S. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2. Int Immunopharmacol. 2023;117:109968. doi: 10.1016/j.intimp.2023.109968.

Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, Aliaga-Raduan F, Carvajal-Rodriguez F, Dutschmann M, et al. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?. Respir Physiol Neurobiol. 2020;277:103443. doi: 10.1016/j.resp.2020.103443.

Arias-Reyes C, Carvajal-Rodriguez F, Poma-Machicao L, Aliaga-Raduán F, Marques DA, Zubieta-DeUrioste N, et al. Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent. PLoS ONE. 2021;16(3):e0237294. doi: 10.1371/journal.pone.0237294.

Accinelli RA, Leon-Abarca JA. At High Altitude COVID-19 Is Less Frequent: The Experience of Peru. Arch Bronconeumol. 2020;56(11):760–1. doi: 10.1016/j.arbres.2020.06.015.

Segovia-Juarez J, Castagnetto JM, Gonzales GF. High altitude reduces infection rate of COVID-19 but not case-fatality rate. Respir Physiol Neurobiol. 2020;281:103494. doi: 10.1016/j.resp.2020.103494.

Cardenas L, Valverde‐Bruffau V, Gonzales GF. Altitude does not protect against SARS‐CoV‐2 infections and mortality due to COVID‐19. Physiol Rep. 2021;9(11):e14922. doi: 10.14814/phy2.14922.

Valverde-Bruffau VJ, Cárdenas L, Gonzales GF. The Pathogenicity of COVID-19 Is Independent of Increasing Altitude: The Case of Colombia. Am J Trop Med Hyg. 2021;104(2):783–5. doi: 10.4269/ajtmh.20-1465.

Vizcardo DA, R Araníbar J, Munayco Escate CV. High altitudes, population density, and poverty: Unraveling the complexities of COVID-19 in Peru during the years 2020-2022. Prev Med Rep. 2023;36:102423. doi: 10.1016/j.pmedr.2023.102423.

Martínez-Briseño D, Pérez-Padilla R, Fernández-Plata R, Castillejos-López M, Higuera-Iglesias AL. The Impact of Altitude on Mortality Rates From COVID-19 in Mexico. Arch Bronconeumol. 2022;58(12):830–3. doi: 10.1016/j.arbres.2022.03.022.

Bridgman C, Gerken J, Vincent J, Brooks AE, Zapata I. Revisiting the COVID-19 fatality rate and altitude association through a comprehensive analysis. Sci Rep. 2022;12(1):18048. doi: 10.1038/s41598-022-21787-z.

Millet GP, Debevec T, Brocherie F, Burtscher M, Burtscher J. Altitude and COVID‐19: Friend or foe? A narrative review. Physiol Rep. 2021;8(24):e14615. doi: 10.14814/phy2.14615.

Nicolaou L, Steinberg A, Carrillo-Larco RM, Hartinger S, Lescano AG, Checkley W. Living at High Altitude and COVID-19 Mortality in Peru. High Alt Med Biol. 2022;23(2):146–58. doi: 10.1089/ham.2021.0149.

Burtscher J, Millet GP, Leitner B, Burtscher M. Health Benefits of Residence at Moderate Altitude Do Not Reduce COVID-19 Mortality. Int J Environ Res Public Health. 2022;19(23):16074. doi: 10.3390/ijerph192316074.

Gore CJ, McSharry PE, Hewitt AJ, Saunders PU. Preparation for football competition at moderate to high altitude. Scand J Med Sci Sports. 2008;18 Suppl 1:85–95. doi: 10.1111/j.1600-0838.2008.00836.x.

Zubieta-Calleja GR, Zubieta-DeUrioste N, de Jesús Montelongo F, Sanchez MGR, Campoverdi AF, Rocco PRM, et al. Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema. Respir Physiol Neurobiol. 2023;309:104000. doi: 10.1016/j.resp.2022.104000.

Santos-Martínez LE, Gómez-Tejada RA, Murillo-Jauregui CX, Hoyos-Paladines RA, Poyares-Jardim CV, Orozco-Levi M. Exposición crónica a la altura. Características clínicas y diagnóstico. Arch Cardiol México. 2021;91(4):500–7. doi: 10.24875/ACM.20000447.

Beraún-Chaca JJ, Villanueva Fernández HS. Clasificación de las regiones naturales del Perú. Boletín del Colegio de Geógrafos del Perú. Número 3. Lima, Perú: CGP; 2016. p. 166-177.

Md Hamzah N, Yu MM, See KF. Assessing the efficiency of Malaysia health system in COVID-19 prevention and treatment response. Health Care Manag Sci. 2021;24(2):273–85. doi: 10.1007/s10729-020-09539-9.

Pham K, Parikh K, Heinrich EC. Hypoxia and Inflammation: Insights From High-Altitude Physiology. Front Physiol. 2021;12:676782. doi: 10.3389/fphys.2021.676782.

Tashi T, Feng T, Koul P, Amaru R, Hussey D, Lorenzo FR, et al. High altitude genetic adaptation in Tibetans: No role of increased hemoglobin–oxygen affinity. Blood Cells Mol Dis. 2014;53(1):27–9. doi: 10.1016/j.bcmd.2014.02.003.

Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, et al. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol. 2020;279:103476. doi: 10.1016/j.resp.2020.103476.

Baquerizo-Sedano L, Goni L, Sayón-Orea C, González-Muniesa P. A U-shaped protection of altitude against mortality and infection of COVID-19 in Peru: an ecological study. BMC Public Health. 2023;23(1):1054. doi: 10.1186/s12889-023-15537-7.

Huang H, Yang L. Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude. Altern Ther Health Med. 2023;29(8):689-693.

Cymerman A. The Physiology of High-Altitude Exposure. En: Marriott BM, Carlson SJ, editores. Nutritional Needs In Cold And In High-Altitude Environments: Applications for Military Personnel in Field Operations. Washington (DC): National Academies Press (US); 1996. p. 295-317. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK232874/.

McVoy MA, Kummarapurugu AB. The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions. J Med Virol. 2025;97(12):e70721. doi: 10.1002/jmv.70721.

Mallet RT, Burtscher J, Pialoux V, Pasha Q, Ahmad Y, Millet GP, et al. Molecular Mechanisms of High-Altitude Acclimatization. Int J Mol Sci. 2023;24(2):1698. doi: 10.3390/ijms24021698.

Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Vishwakarma R, AlFaifi M, et al. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study. Clin Appl Thromb Hemost. 2023;29:10760296231218216. doi: 10.1177/10760296231218216.

Giovanelli L, Malacarne M, Pagani M, Biolo G, Mekjavic IB, Bernardelli G, et al. Moderate Aerobic Exercise Reduces the Detrimental Effects of Hypoxia on Cardiac Autonomic Control in Healthy Volunteers. J Pers Med. 2023;13(4):585. doi: 10.3390/jpm13040585.